CG Oncology, Inc Common stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $52 | $456 | $43 |
Gross Profit | -156 | 52 | 456 | 43 |
EBITDA | -48,741 | -42,180 | -38,049 | -28,274 |
EBIT | -42,204 | -38,017 | -28,295 | |
Net Income | -41,426 | -34,452 | -31,798 | -20,405 |
Net Change In Cash | 0 | 52 | 456 | 43 |
Free Cash Flow | -27,973 | -29,293 | -20,871 | -15,918 |
Cash | 14,624 | 41,472 | 257,068 | 43,411 |
Basic Shares | 76,226 | 76,187 | 64,820 | 67,143 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,139 | $204 | $191 | $10,358 |
Gross Profit | 1,139 | 204 | 176 | 10,348 |
EBITDA | -114,634 | -55,432 | -35,231 | -12,378 |
EBIT | -114,666 | -55,449 | -35,246 | -12,388 |
Net Income | -88,039 | -48,607 | -35,443 | -12,839 |
Net Change In Cash | 1,139 | 204 | 191 | 10,358 |
Free Cash Flow | -78,947 | -45,679 | -29,818 | -13,751 |
Cash | 257,068 | 8,266 | 88,143 | 53,607 |
Basic Shares | 62,496 | 66,636 | 66,636 | 66,636 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.54 |
2025-03-31 | -$0.45 |
2024-12-31 | -$0.46 |
